Cohort study reveals minimal excess risk of death, myocardial infarction, or stroke in type 2 diabetes with controlled risk factors, indicating substantial protective benefits.
Patients with type 2 diabetes who had five risk-factor variables within the target ranges appeared to have little or no excess risk of death, myocardial infarction, or stroke, as compared with the general population. (Funded by the Swedish Association of Local Authorities and Regions and others.).
No takes yet. Share an insight, caveat, or question.
Rawshani et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: